Stockscreener 앱 받기
313.82
1.23%
3.81
시간 외 거래:
313.87
0.05
+0.02%
전일 마감가:
$310.01
열려 있는:
$304.78
하루 거래량:
1.30M
Relative Volume:
0.81
시가총액:
$59.89B
수익:
$328.68B
순이익/손실:
$2.55B
주가수익비율:
24.08
EPS:
13.0349
순현금흐름:
$1.56B
1주 성능:
-2.07%
1개월 성능:
+3.82%
6개월 성능:
-13.03%
1년 성능:
+6.43%
1일 변동 폭
$302.01
$314.31
1주일 범위
$302.01
$333.95
52주 변동 폭
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
313.82 | 59.95B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
869.00 | 102.45B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
235.17 | 54.46B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
89.77 | 10.11B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.27 | 1.26B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity - finance.yahoo.com
Cencora (NYSE:COR) Releases FY 2026 Earnings Guidance - MarketBeat
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora Inc (COR) Shares Fall 5.9% -- What GF Score of 77 Tells Investors - GuruFocus
Cencora: Walgreens Volume Disruption Raises New Concern, but We Make No Changes for Now - morningstar.com
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled - TradingKey
Cencora reaffirms $17.75-$17.95 FY26 EPS guidance amid Walgreens shift - scanx.trade
Cencora Says Certain Serviced Walgreens Volume Began Moving Outside Company; Reaffirms 2026 EPS Outlook - marketscreener.com
Cencora (COR) Reaffirms FY2026 Guidance as Walgreens Volume Tran - GuruFocus
Cencora maintains earnings guidance as some Walgreens volume moves away - Investing.com India
Cencora Reports Walgreens Volume Transition, Confirms FY2026 Adjusted EPS Forecast - Kalkine Media
Cencora dips on loss of some Walgreens business (COR:NYSE) - Seeking Alpha
Cencora says Walgreens volumes shift, reaffirms guidance, shares sink By Investing.com - Investing.com Canada
Form 8K Cencora Inc For: 12 August By Investing.com - Investing.com Canada
Cencora (NYSE:COR) Shares Gap DownWhat's Next? - MarketBeat
Is Wall Street Bullish or Bearish on Cencora Stock? - finance.yahoo.com
Wedge Capital Management L L P NC Increases Position in Cencora, Inc. $COR - MarketBeat
Insight Wealth Strategies LLC Purchases 6,648 Shares of Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (NYSE:COR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora, Inc. $COR Shares Sold by Handelsbanken Fonder AB - MarketBeat
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cencora (COR) Posts Strong Q3 Earnings, Is The 9% Upside Enough? - simplywall.st
Cencora, Inc. (COR) Stock Analysis: Healthcare Distribution Giant with a 14.60% Upside Potential - DirectorsTalk Interviews
Cencora Inc (COR) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
The Bull Case For Cencora (COR) Could Change Following Raised EPS Outlook And Bigger Buybacks And Dividend - simplywall.st
Cencora Inc (COR) Stock News Today - TradingKey
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Encourages Cencora, Inc. (COR) - The National Law Review
JPMorgan Adjusts Price Target on Cencora to $390 From $382 - Moomoo
Cencora, Inc. $COR Holdings Lifted by Assenagon Asset Management S.A. - MarketBeat
Corebridge Financial (COR) plans sale of 20,000 common shares under Rule 144 - Stock Titan
Leerink Partners Adjusts Price Target on Cencora to $380 From $368 - marketscreener.com
Evercore ISI Adjusts Price Target on Cencora to $350 From $330 - marketscreener.com
Citigroup Adjusts Price Target on Cencora to $370 From $355 - Yahoo Finance
Baird Adjusts Price Target on Cencora to $370 From $340 - Yahoo Finance
Cencora Expands Credit Facilities to Bolster Liquidity - The Globe and Mail
Cencora (COR) Stock Climbs As Margin Expansion Drives Profit Momentum - Sahm
Cencora, Inc. (COR) Stock forecasts - Yahoo Finance Singapore
Cencora, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Cencora, Inc. (NYSE:COR) Announces $0.60 Quarterly Dividend - MarketBeat
Cencora Inc (COR) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Cencora Inc (COR) (Q3 2026) Earnings Call Highlights: Strong Double-Digit Growth and Raised Guidance - finance.yahoo.com
Cencora Inc (COR) (Q3 2026) Earnings Call Highlights: Strong Dou - GuruFocus
Strong Performance From Cencora's Specialty Assets Looks Durable and Offsets Industry Headwinds - Morningstar
Cencora Q3 fiscal 2026 slides show specialty strength, raised guidance - Investing.com
Cencora, Inc. 2026: Revenue $84.75B, EPS $3.94— 10-Q Summary - TradingView
Cencora (COR) Expands Credit Facilities And Resets Receivables Terms - Yahoo Finance
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.70%
0.39%
자본화:
|
볼륨(24시간):